TaqMan mutation detection assays

Friday, 21 October, 2011 | Supplied by: Applied Biosystems Pty Ltd



TaqMan mutation detection assays detect and measure somatic mutations in genes associated with cancer.

The research-only assays are based on a technology known as competitive allele-specific PCR technology, also known as castPCR technology.

The technology is highly specific and sensitive and can detect and quantitate rare quantities of mutated DNA in a sample that contains large quantities of normal, wild-type DNA.

It is sensitive enough to detect a single mutant molecule out of 1 million normal copies, a 10-fold greater sensitivity than other mutation detection assays.

The first three assays available are designed for detecting mutations in the KRAS, BRAF and EGFR genes. However, more assays are in development for many more cancer-related genes.

Online: www.appliedbiosystems.com
Phone: 03 9730 8600
Related Products

InSite L. mono Glo swab test for Listeria

InSite L. mono Glo is a self-contained swab system for the simultaneous detection of...

Thermo Scientific Aquilos 2 Cryo-FIB DualBeam system

The Thermo Scientific Aquilos 2 Cryo-FIB DualBeam system is dedicated to the preparation of thin,...

Abcam engineered knockout cell lysates

Abcam's engineered knockout cell lysates enable proteomic studies by providing researchers...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd